People with leukaemia are more prone to infection – but not from one particular herpes virus

March 19, 2014, University of Vienna
People with leukaemia are more prone to infection – but not from one particular herpes virus
People with leukaemia are more prone to infection – but not from one particular herpes virus.

People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers at the MedUni Vienna's University Department of Internal Medicine I have now discovered that this doesn't apply to the cytomegalovirus (CMV).

As part of their research into the presently incurable condition of chronic lymphocytic leukaemia (CLL), the scientists led by Katrina Vanura and study leader Christoph Steininger have discovered that CLL patients have increased numbers of antibodies against the .

Around 80 Austrians develop each year, and around 500 people currently attend the Clinical Department of Haematology and Haemostasiology with the condition. These patients are on average 65 years old, as the condition progresses slowly and is often diagnosed secondary to an incidental finding. The cytomegalovirus (CMV) is a DNA that belongs to same class as the herpes virus and is carried in its "dormant" form by around 60 per cent of the population. People with an intact immune system have nothing to fear from CMV.

In patients who are immunosuppressed following transplants, people with HIV and people who, for any other reason, have a weakened immune system, however, CMV can have serious consequences: fevers lasting weeks, raised liver enzymes and even severe organ damage. Says Steininger: "CMV is also the most common viral cause of deformities during pregnancy since the introduction of the rubella vaccine." As a result, a preventative CMV vaccination for mothers-to-be could be used alongside their immunisations against rubella in order to prevent deformities of or developmental problems with the embryo.

Previous research into the development of a CMV vaccine confirmed

Two vaccinations against the cytomegalovirus are currently already in phase II / III studies. In the current CLL study, the Vienna researchers were able to demonstrate that the development of a CMV vaccine is focusing on the correct protein, namely glycoprotein B. During an initial infection, the immune system forms defence factors against a variety of virus proteins, but if a further infection occurs it only remembers a small group of viral proteins, to which glycoprotein B belongs.

Dormant CMV virus is constantly being fought in CLL patients

Unlike other infections, cases of CMV among CLL patients are of lesser consequence. This is most likely due to the fact that the successfully fights the dormant CMV virus whenever it is reawaken, thereby training the system up. Even in the later stages of leukaemia, there are still adequate defence factors available to prevent the virus from causing illness.

Explore further: Novel vaccine approach to human cytomegalovirus found effective

More information: Vanura K, Rieder F, Kastner M-T, Biebl J, Sandhofer M, et al. (2013)" Chronic Lymphocytic Leukemia Patients Have a Preserved Cytomegalovirus-Specific Antibody Response despite Progressive Hypogammaglobulinemia." PLoS ONE 8(10): e78925. DOI: 10.1371/journal.pone.0078925

Related Stories

Novel vaccine approach to human cytomegalovirus found effective

September 18, 2013
An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more ...

Researchers show long-term consequences of chronic virus infection

August 16, 2012
The cytomegalovirus (CMV) is a member of the herpesvirus family. Although most people carry CMV for life, it hardly ever makes them sick. Researchers from the Helmholtz Centre for Infection Research and from the USA have ...

How a virus might make you diabetic later in life

August 27, 2012
Cytomegalovirus (CMV) is one of the viruses that most infected people carry without ill effects. Once infected you are infected for life and, although it normally is dormant, it can become active again at any point in time. ...

Test approved to help treat common infection in transplant patients

July 5, 2012
(HealthDay) -- The first DNA test to help doctors treat a common viral infection in people who have had a solid organ transplant has been approved by the U.S. Food and Drug Administration.

Novel drug prevents common viral disease in stem-cell transplant patients, study finds

September 25, 2013
A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham ...

Risk of cytomegalovirus infection following lung transplant now more measurable

June 25, 2012
(Medical Xpress) -- Researchers in the Department of Virology and the Clinical Department of Thoracic Surgery at the MedUni Vienna have demonstrated that the risk of cytomegalovirus infection following lung transplant can ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.